Optovue Inc. Company Profile
RTVue was the first FDA cleared Fourier domain (also known as spectral domain) OCT launched in the United States, and also the first OCT cleared by the U.S. Food and Drug Administration for both corneal and retinal imaging. The iVue is the compact fourier-domain version of the RTVue OCT, offering the same scanning speed and resolution as the larger system, that includes scanning and reports for retina, retina nerve fiber and cornea assessment by the clinician.
News Articles
Haag-Streit USA and Optovue Team Up to Introduce Octopus/Optovue Bundle
MASON, Ohio, April 26, 2013 /PRNewswire-iReach/ -- Haag-Streit USA and Optovue have joined forces to bundle Haag-Streit's Octopus perimeter with Optovue's Optical Coherence Tomography (OCT) tech...
Optovue scores 510(k) clearance for OCT system database
Optovue has been cleared by the FDA to incorporate a normative database into the firm's iVue spectral-domain optical coherenc -More-
Drugs and Medications
None
PubMed Articles
OBJECTIVE: To determine the intra and inter-user reliability of central corneal thickness (CCT) measurements obtained using a portable spectral-domain optical coherence tomography (SD-OCT) device in h...
Pattern electroretinogram association with spectral domain-OCT structural measurements in glaucoma.
PurposeTo describe the association between pattern electroretinogram (PERG) amplitude and spectral domain-optical coherence tomography (SD-OCT) macular thickness, retinal nerve fibre layer (RNFL) thic...
PURPOSE: Morphologic evaluation of the cornea is based on the slit-lamp examination. In human ophthalmology, optical coherence tomography (OCT) has opened a new field in the clinical approach to anter...
Purpose: To evaluate the effect of disease severity and optic disc size on the diagnostic accuracies of optic nerve head (ONH), retinal nerve fiber layer (RNFL) and macular parameters with RTVue (Opto...
Clinical Trials
Corneal and Anterior Segment Optical Coherence Tomography - Optovue
The objective of the study is to further develop clinical applications for the high speed corneal and anterior segment optical coherence tomography (CAS-OCT) system developed by Optovue, I...
Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound
The purpose of this study is to assess the repeatability, reproducibility, and agreement of central corneal thickness measured by Fourier Domain Optical Coherence tomography (FD-OCT, OptoV...
Companies
Optovue Incorporated is a privately-held ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities tha...
RTVue was the first FDA cleared Fourier domain (also known as spectral domain) OCT launched in the United States, and also the first OCT cleared by the U.S. Food and Drug Administration for both corne...
More Information about "Optovue Inc." on BioPortfolio
We have published hundreds of Optovue Inc. news stories on BioPortfolio along with dozens of Optovue Inc. Clinical Trials and PubMed Articles about Optovue Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Optovue Inc. Companies in our database. You can also find out about relevant Optovue Inc. Drugs and Medications on this site too.
